Efficacy of traditional Chinese medicine in treating cancer (Review)

  • Authors:
    • Jiao Nie
    • Changlin Zhao
    • Li Deng
    • Jia Chen
    • Bin Yu
    • Xianlin Wu
    • Peng Pang
    • Xiaoyin Chen
  • View Affiliations

  • Published online on: November 5, 2015     https://doi.org/10.3892/br.2015.537
  • Pages: 3-14
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The morbidity associated with cancer has rapidly increased in recent years, and in the previous 5 years has had a tendency to be the leading cause of fatality compared with cardiovascular disease. Therefore, effective measures are required with an aim to reduce the incidence. Based on the results of clinical investigation, a multidisciplinary treatment strategy for cancer, which includes radiotherapy, chemotherapy, surgery, targeted therapy and immunotherapy, are prominently used in clinical practice. However, the therapies are insufficient due to multidrug resistance, adverse effects and the presence of the root of the cancer. Therefore, there is a necessity to develop more effective or adjunctive therapies for cancer prevention and treatment. Cancer is now widely recognized as a systemic humoral disease. Similarly, the function of herbal drugs is to modulate the whole body system in a more holistic way. Recently, herbal drugs have been applied to one of the efficient approaches for cancer therapy. Furthermore, there is evidence that various herbal medicines have been proven to be useful and effective in sensitizing the conventional agents against the various factors at the cellular and molecular levels that are associated with the occurrence of cancer and in prolonging survival time, alleviating side effects of chemotherapy and radiotherapy and improving the quality of life in cancer patients.

References

1 

Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D, Brawley OW and Wender R: Cancer screening in the United States, 2015: A review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin. 65:30–54. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Bray F, Jemal A, Grey N, Ferlay J and Forman D: Global cancer transitions according to the Human Development Index (2008–2030): A population-based study. Lancet Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Adams C, Grey N, Magrath I, Miller A and Torode J: The World Cancer Declaration: Is the world catching up? Lancet Oncol. 11:1018–1020. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Bailly C: Ready for a comeback of natural products in oncology. Biochem Pharmacol. 77:1447–1457. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Li X, Yang G, Li X, Zhang Y, Yang J, Chang J, Sun X, Zhou X, Guo Y, Xu Y, et al: Traditional Chinese medicine in cancer care: A review of controlled clinical studies published in chinese. PLoS One. 8:e603382013. View Article : Google Scholar : PubMed/NCBI

6 

Sen T and Samanta SK: Medicinal plants, human health and biodiversity: A broad review. Adv Biochem Eng Biotechnol. 147:59–110. 2015.PubMed/NCBI

7 

Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR, et al: Cancer prevention and therapy through the modulation of the tumor microenvironment. Semin Cancer Biol. Apr 10–2015.(Epub ahead of print) doi: 10.1016/j.semcancer.2015.02.007. View Article : Google Scholar : PubMed/NCBI

8 

Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 71:1397–1421. 2006. View Article : Google Scholar : PubMed/NCBI

9 

Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z and Han J: The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci Trends. 9:16–34. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Jenkins VK, Timmons AK and McCall K: Diversity of cell death pathways: Insight from the fly ovary. Trends Cell Biol. 23:567–574. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Elmore S: Apoptosis: A review of programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Boatright KM and Salvesen GS: Mechanisms of caspase activation. Curr Opin Cell Biol. 15:725–731. 2003. View Article : Google Scholar : PubMed/NCBI

13 

Romero A, Novoa B and Figueras A: The complexity of apoptotic cell death in mollusks: An update. Fish Shellfish Immunol. 46:79–87. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Hengartner MO: The biochemistry of apoptosis. Nature. 12:770–776. 2000. View Article : Google Scholar

15 

Hensley P, Mishra M and Kyprianou N: Targeting caspases in cancer therapeutics. Biol Chem. 394:831–843. 2013. View Article : Google Scholar : PubMed/NCBI

16 

de Poot SA, Lai KW, van der Wal L, Plasman K, Van Damme P, Porter AC, Gevaert K and Bovenschen N: Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis. Cell Death Differ. 21:416–426. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Chuang CH, Wang WJ, Li CF, Ko CY, Chou YH, Chuu CP, Cheng TL and Wang JM: The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer. Cell Death Dis. 5:e12202014. View Article : Google Scholar : PubMed/NCBI

18 

Lin J, Chen Y, Wei L, Chen X, Xu W, Hong Z, Sferra TJ and Peng J: Hedyotis Diffusa Willd extract induces apoptosis via activation of the mitochondrion-dependent pathway in human colon carcinoma cells. Int J Oncol. 37:1331–1338. 2010.PubMed/NCBI

19 

Ling Q, Xu X, Wei X, Wang W, Zhou B, Wang B and Zheng S: Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. J Exp Clin Cancer Res. 30:662011. View Article : Google Scholar : PubMed/NCBI

20 

Guo B, Zhang T, Su J, Wang K and Li X: Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells. Cancer Chemother Pharmacol. 75:353–363. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Hu M, Zhao M, An C, Yang M, Li Q, Zhang Y, Suetsugu A, Tome Y, Yano S, Fu Y, et al: Real-time imaging of apoptosis induction of human breast cancer cells by the traditional Chinese medicinal herb tubeimu. Anticancer Res. 32:2509–2514. 2012.PubMed/NCBI

22 

Hsu SC and Chung JG: Anticancer potential of emodin. BioMedicine. 2:108–116. 2012. View Article : Google Scholar

23 

Zhang YK, Wang YJ, Gupta P and Chen ZS: Multidrug resistance proteins (MRPs) and cancer therapy. AAPS J. 17:802–812. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Wilkens S: Structure and mechanism of ABC transporters. F1000 Prime Rep. 7:142015. View Article : Google Scholar

25 

Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 5:219–234. 2006. View Article : Google Scholar : PubMed/NCBI

26 

Leslie EM, Deeley RG and Cole SP: Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol. 204:216–237. 2005. View Article : Google Scholar : PubMed/NCBI

27 

Li Y, Fan L, Sun Y, Miao X, Zhang F, Meng J, Han J, Zhang D, Zhang R, Yue Z, et al: Paris saponin VII from Trillium tschonoskii reverses multidrug resistance of adriamycin-resistant MCF-7/ADR cells via P-glycoprotein inhibition and apoptosis augmentation. J Ethnopharmacol. 154:728–734. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Cort A and Ozben T: Natural product modulators to overcome multidrug resistance in cancer. Nutr Cancer. 67:411–423. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Eichhorn T and Efferth T: P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs. J Ethnopharmacol. 141:557–570. 2012. View Article : Google Scholar : PubMed/NCBI

30 

Ugocsai K, Varga A, Molnár P, Antus S and Molnár J: Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug-resistant colon cancer cells expressing MDR1/LRP. Vivo. 19:433–438. 2005.

31 

Nabekura T, Kamiyama S and Kitagawa S: Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem Biophys Res Commun. 327:866–870. 2005. View Article : Google Scholar : PubMed/NCBI

32 

Xie XH, Zhao H, Hu YY and Gu XD: Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells. Exp Ther Med. 8:1611–1615. 2014.PubMed/NCBI

33 

Hu T, To KK, Wang L, Zhang L, Lu L, Shen J, Chan RL, Li M, Yeung JH and Cho CH: Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza. Phytomedicine. 21:1264–1272. 2014. View Article : Google Scholar : PubMed/NCBI

34 

Adams M, Mahringer A, Kunert O, Fricker G, Efferth T and Bauer R: Cytotoxicity and p-glycoprotein modulating effects of quinolones and indoloquinazolines from the Chinese herb Evodia rutaecarpa. Planta Med. 73:1554–1557. 2007. View Article : Google Scholar : PubMed/NCBI

35 

Adams M, Mahringer A, Bauer R, Fricker G and Efferth T: In vitro cytotoxicity and P-glycoprotein modulating effects of geranylated furocoumarins from Tetradium daniellii. Planta Med. 73:1475–1478. 2007. View Article : Google Scholar : PubMed/NCBI

36 

Wu JY, Yu ZL, Fong WF and Shi YQ: Chemotherapeutic activities of Carthami Flos and its reversal effect on multidrug resistance in cancer cells. Afr J Tradit Complement Altern Med. 10:36–40. 2013.PubMed/NCBI

37 

Gordon MS, Mendelson DS and Kato G: Tumor angiogenesis and novel antiangiogenic strategies. Int J Cancer. 126:1777–1787. 2010.PubMed/NCBI

38 

Bikfalvi A, Moenner M, Javerzat S, North S and Hagedorn M: Inhibition of angiogenesis and the angiogenesis/invasion shift. Biochem Soc Trans. 39:1560–1564. 2011. View Article : Google Scholar : PubMed/NCBI

39 

Ziche M and Morbidelli L: Molecular regulation of tumour angiogenesis by nitric oxide. Eur Cytokine Netw. 20:164–170. 2009.PubMed/NCBI

40 

Jinushi M: Immune regulation of therapy-resistant niches: Emerging targets for improving anticancer drug responses. Cancer Metastasis Rev. 33:737–745. 2014. View Article : Google Scholar : PubMed/NCBI

41 

Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, et al: Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol. Jan 15–2015.(Epub ahead of print) doi: 10.1016/j.semcancer.2015.01.001. View Article : Google Scholar

42 

Cook KM and Figg WD: Angiogenesis inhibitors: Current strategies and future prospects. CA Cancer J Clin. 60:222–243. 2010. View Article : Google Scholar : PubMed/NCBI

43 

Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, et al: VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell. 22:21–35. 2012. View Article : Google Scholar : PubMed/NCBI

44 

Eikesdal HP and Kalluri R: Drug resistance associated with antiangiogenesis therapy. Semin Cancer Biol. 19:310–317. 2009. View Article : Google Scholar : PubMed/NCBI

45 

Wei L, Lin J, Xu W, Cai Q, Shen A, Hong Z and Peng J: Scutellaria barbata D. Don inhibits tumor angiogenesis via suppression of Hedgehog pathway in a mouse model of colorectal cancer. Int J Mol Sci. 13:9419–9430. 2012. View Article : Google Scholar : PubMed/NCBI

46 

Yan B, Liu L, Zhao Y, Xiu LJ, Sun DZ, Liu X, Lu Y, Shi J, Zhang YC, Li YJ, et al: Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells. World J Gastroenterol. 20:13105–13118. 2014. View Article : Google Scholar : PubMed/NCBI

47 

Wang XF, Zhou QM, Du J, Zhang H, Lu YY and Su SB: Baicalin suppresses migration, invasion and metastasis of breast cancer via p38MAPK signaling pathway. Anticancer Agents Med Chem. 13:923–931. 2013. View Article : Google Scholar : PubMed/NCBI

48 

Shen A, Lin J, Chen Y, Lin W, Liu L, Hong Z, Sferra TJ and Peng J: Pien Tze Huang inhibits tumor angiogenesis in a mouse model of colorectal cancer via suppression of multiple cellular pathways. Oncol Rep. 30:1701–1706. 2013.PubMed/NCBI

49 

Li F, Wang Y, Wang X, Li J, Cui H and Niu M: Ganoderic acids suppress growth and angiogenesis by modulating the NF-κB signaling pathway in breast cancer cells. Int J Clin Pharmacol Ther. 50:712–721. 2012. View Article : Google Scholar : PubMed/NCBI

50 

Wen-Sheng W: ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Oncogene. 22:955–963. 2003. View Article : Google Scholar : PubMed/NCBI

51 

Lee Y-C, Cheng TH, Lee JS, Chen JH, Liao YC, Fong Y, Wu CH and Shih YW: Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells. Mol Cell Biochem. 347:103–115. 2011. View Article : Google Scholar : PubMed/NCBI

52 

Wang N and Feng Y, Cheung F, Wang X, Zhang Z and Feng Y: A Chinese medicine formula Gegen Qinlian decoction suppresses expansion of human renal carcinoma with inhibition of matrix metalloproteinase-2. Integr Cancer Ther. 14:75–85. 2015. View Article : Google Scholar : PubMed/NCBI

53 

Spurrell EL and Lockley M: Adaptive immunity in cancer immunology and therapeutics. Ecancermedicalscience. 8:4412014.PubMed/NCBI

54 

Xiao W, Wu K, Yin M, Han S, Ding Y, Qiao A, Lu G, Deng B, Bo P and Gong W: Wogonin inhibits tumor-derived regulatory molecules by suppressing STAT3 signaling to promote tumor immunity. J Immunother. 38:167–84. 2015. View Article : Google Scholar : PubMed/NCBI

55 

Fridman WH, Pagès F, Sautès-Fridman C and Galon J: The immune contexture in human tumours: Impact on clinical outcome. Nat Rev Cancer. 12:298–306. 2012. View Article : Google Scholar : PubMed/NCBI

56 

Huang CF, Lin SS, Liao PH, Young SC and Yang C-C: The immunopharmaceutical effects and mechanisms of herb medicine. Cell Mol Immunol. 5:23–31. 2008. View Article : Google Scholar : PubMed/NCBI

57 

Peng Q, Cai H, Sun X, Li X, Mo Z and Shi J: Alocasia cucullata exhibits strong antitumor effect in vivo by activating antitumor immunity. PLoS One. 8:e753282013. View Article : Google Scholar : PubMed/NCBI

58 

Ma YH, Cheng WZ, Gong F, Ma AL, Yu QW, Zhang JY, Hu CY, Chen XH and Zhang DQ: Active Chinese mistletoe lectin-55 enhances colon cancer surveillance through regulating innate and adaptive immune responses. World J Gastroenterol. 14:5274–5281. 2008. View Article : Google Scholar : PubMed/NCBI

59 

Sun S, Zheng K, Zhao H, Lu C, Liu B, Yu C, Zhang G, Bian Z, Lu A and He X: Regulatory effect of astragalus polysaccharides on intestinal intraepithelial γδT cells of tumor bearing mice. Molecules. 19:15224–15236. 2014. View Article : Google Scholar : PubMed/NCBI

60 

Su ZY and Sheen LY: An evidence-based perspective of Ganoderma Lucidum (Lucid Ganoderma) for cancer patients. Evidence-based Anticancer Materia Medica. Cho W.C.S.: Springer. 245–263. 2011. View Article : Google Scholar

61 

de la Taille A, Hayek OR, Burchardt M, Burchardt T and Katz AE: Role of herbal compounds (PC-SPES) in hormone-refractoryprostate cancer: Two case reports. J Altern Complement Med. 6:449–451. 2000. View Article : Google Scholar : PubMed/NCBI

62 

Hsieh TC and Wu JM: Mechanism of action of herbal supplement PC-SPES: Elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells. Int J Oncol. 20:583–588. 2002.PubMed/NCBI

63 

Gao Y, Zhou S, Jiang W, Huang M and Dai X: Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 32:201–215. 2003. View Article : Google Scholar : PubMed/NCBI

64 

Donohoe CL, Ryan AM and Reynolds JV: Cancer cachexia: Mechanisms and clinical implications. Gastroenterol Res Pract. 2011:6014342011. View Article : Google Scholar : PubMed/NCBI

65 

Zhang L, Wu C, Zhang Y, Liu F, Wang X, Zhao M and Hoffman RM: Comparison of efficacy and toxicity of traditional Chinese medicine (TCM) herbal mixture LQ and conventional chemotherapy on lung cancer metastasis and survival in mouse models. PLoS One. 9:e1098142014. View Article : Google Scholar : PubMed/NCBI

66 

Zhang L, Wu C, Zhang Y, Liu F, Zhao M, Bouvet M and Hoffman RM: Efficacy comparison of traditional Chinese medicine LQ versus gemcitabine in a mouse model of pancreatic cancer. J Cell Biochem. 114:2131–2137. 2013. View Article : Google Scholar : PubMed/NCBI

67 

Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, Li XK and Tang W: Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends. 4:297–307. 2010.PubMed/NCBI

68 

Zhou QM, Wang XF, Liu XJ, Zhang H, Lu YY, Huang S and Su SB: Curcumin improves MMC-based chemotherapy by simultaneously sensitising cancer cells to MMC and reducing MMC-associated side-effects. Eur J Cancer. 47:2240–2247. 2011. View Article : Google Scholar : PubMed/NCBI

69 

Shakibaei M, Kraehe P, Popper B, Shayan P, Goel A and Buhrmann C: Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer. BMC Cancer. 15:2502015. View Article : Google Scholar : PubMed/NCBI

70 

Wang H, Chan YL, Li TL and Wu CJ: Improving cachectic symptoms and immune strength of tumour-bearing mice in chemotherapy by a combination of Scutellaria baicalensis and Qing-Shu-Yi-Qi-Tang. Eur J Cancer. 48:1074–1084. 2012. View Article : Google Scholar : PubMed/NCBI

71 

Li SG, Chen HY, Ou-Yang CS, Wang X-X, Yang Z-J, Tong Y and Cho WC: The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: A systematic review and meta-analysis. PLoS One. 8:e576042013. View Article : Google Scholar : PubMed/NCBI

72 

Singh SR, Tan M and Rameshwar P: Cancer metabolism: Targeting metabolic pathways in cancer therapy. Cancer Lett. 356(2 Pt A): 147–148. 2015. View Article : Google Scholar : PubMed/NCBI

73 

Nowarski R, Gagliani N, Huber S and Flavell RA: Innate immune cells in inflammation and cancer. Cancer Immunol Res. 1:77–84. 2013. View Article : Google Scholar : PubMed/NCBI

74 

Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E and Capaccioli S: Natural compounds for cancer treatment and prevention. Pharmacol Res. 59:365–378. 2009. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

January 2016
Volume 4 Issue 1

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Nie, J., Zhao, C., Deng, L., Chen, J., Yu, B., Wu, X. ... Chen, X. (2016). Efficacy of traditional Chinese medicine in treating cancer (Review). Biomedical Reports, 4, 3-14. https://doi.org/10.3892/br.2015.537
MLA
Nie, J., Zhao, C., Deng, L., Chen, J., Yu, B., Wu, X., Pang, P., Chen, X."Efficacy of traditional Chinese medicine in treating cancer (Review)". Biomedical Reports 4.1 (2016): 3-14.
Chicago
Nie, J., Zhao, C., Deng, L., Chen, J., Yu, B., Wu, X., Pang, P., Chen, X."Efficacy of traditional Chinese medicine in treating cancer (Review)". Biomedical Reports 4, no. 1 (2016): 3-14. https://doi.org/10.3892/br.2015.537